Welcome to our dedicated page for Well Health Tech news (Ticker: WHTCF), a resource for investors and traders seeking the latest updates and insights on Well Health Tech stock.
WELL Health Technologies Corp. (WHTCF) is a digital healthcare company that frequently issues detailed updates on its clinic operations, technology platform, and financial performance. News about WELL often highlights developments across its Canadian Patient Services segment, its U.S. specialty markets, and its majority‑owned SaaS subsidiary, WELLSTAR Technologies Corp.
Investors following WHTCF news can expect regular coverage of quarterly results, including trends in revenue, adjusted EBITDA, and patient visits across the company’s clinic network. WELL also reports on clinic acquisitions, expansion of its Canadian clinics platform, and changes to its senior secured credit facility that support its acquisition pipeline and growth plans.
Another major theme in WELL’s news flow is clinic digitization and AI‑enabled tools. The company provides updates on the progress of digital transformation in its primary care clinics, including adoption of online booking, self‑check‑in, digital reminders, and digital consents. It also announces new AI‑powered products and deployments across its network, such as AI ambient scribe solutions and decision support tools.
WELLSTAR‑related announcements are an important component of WELL’s news. These items cover WELLSTAR’s recurring revenue growth, new contracts for digital health platforms, acquisitions of SaaS and billing assets, and equity financings intended to fund future growth and potential spin‑out plans. Together, these updates offer insight into WELL’s combined strategy of operating a large outpatient clinic network while scaling a healthcare technology platform.
For readers tracking WHTCF, this news page aggregates company press releases and market‑moving updates in one place, making it easier to review WELL’s operational milestones, technology initiatives, and capital markets activity over time.
WELL Health (OTCQX: WHTCF) partnered with AliveCor to provide AI-powered Kardia ECG monitoring with cardiologist-reviewed Clinician Reviews for Canadian users starting April 2, 2026.
Canadian-registered cardiologists in WELL’s network review Kardia ECGs within 24 hours, supplementing AI results (Kardia: >350 million ECGs recorded; AI detects three common arrhythmias) and generating clinical services revenue per review.
WELL Health (TSX: WHTCF) supports Ontario’s plan for a provincewide Primary Care Medical Record system backed by $3.4 billion in primary care funding to connect about 2 million more residents by 2029. WELL says its majority-owned WELLSTAR already supports ~8,165 physicians and 1,669 clinics in Ontario via provincially certified EMRs.
WELL intends to participate in the Province’s open, multi-vendor procurement led by Supply Ontario, citing its OSCAR Pro, Nexus AI™, OceanMD and broader WELL ecosystem as fit-for-purpose for interoperability, referrals, AI-enabled workflows and cybersecurity.
WELL Health Technologies (OTCQX: WHTCF) reported record FY2025 results with $1.40B revenue (+52% YoY) and $203.7M Adjusted EBITDA (+336% YoY; 14.5% margin). Canadian Patient Services revenue rose to $444.3M (+39%) with Adjusted EBITDA of $58.1M (+43%). Operating free cash flow to shareholders was $58.2M. Management provided 2026 guidance of $1.55–1.65B revenue and $175–185M Adjusted EBITDA, and completed credit facility expansion to $400M. The company cited acquisitions, organic growth and HEALWELL inclusion as drivers and plans a WELLSTAR spin-out.
WELL Health (OTCQX: WHTCF) said majority-owned WELLSTAR completed two billing acquisitions—PatientSERV (Ontario) and Lambert (Québec)—expanding billing coverage to six provinces. Total consideration was ~$4.8M plus up to $6.3M in contingent payouts. The assets are expected to add ~$5M revenue with EBITDA margins approaching 20%, taking WELLSTAR to an annualized run-rate of ~$84M. WELLSTAR also has a $62M equity financing and reaffirms the planned spin-out and a target $100M revenue run-rate by year-end.
WELL Health (TSX: WELL; OTCQX: WHTCF) will release its Fiscal Fourth Quarter and Year End 2025 results for the period ended December 31, 2025 before market open on Thursday, March 19, 2026. A conference call and webcast to discuss results is scheduled the same day at 1:00 PM ET / 10:00 AM PT, hosted by CEO Hamed Shahbazi and CFO Eva Fong. Investors are asked to dial in 10 minutes early or register to attend the webcast at well.company/events.
WELL Health (OTCQX: WHTCF) reported a record 4.28 million Canadian patient visits in 2025, up 37% YoY and 10% organic. The Canadian network reached 252 clinics and 3,119 providers (27% YoY). Patient satisfaction was high: primary care NPS 80 from 77,500 reviews and Diagnostics Centres ~50,000 Google reviews averaging 4.8–4.9.
WELL added 41 clinics in 2025 (25 in Q4) and reported inorganic growth of 27%, while physician membership grew 34% YoY, highlighting continued clinic expansion and practitioner recruitment.
WELL Health (OTCQX: WHTCF) completed a strategic acquisition and upsized its senior secured credit facility to support clinic growth and e-consult expansion. WELL acquired eight Alberta clinics and a 61% interest in an e-consult platform for approximately $33 million, creating proforma annual revenue of ~ $45 million with ~48% gross margins and >20% operating Adjusted EBITDA margins. The new credit facility increases committed capacity to $400 million (plus $100 million accordion), extends the term to 2030, and leaves >$195 million available capacity to fund a ~ $245 million pipeline of clinic opportunities.
WELL Health Technologies (OTCQX: WHTCF) released a CEO letter dated January 21, 2026 from Founder, Chairman and CEO Hamed Shahbazi outlining the company’s strategic priorities and guiding principles for 2026. The letter frames WELL’s next phase of growth and emphasizes the company’s focus on leveraging technology to support healthcare practitioners and patient outcomes globally. The CEO letter is available on the company website for investors and stakeholders to review.
WELLSTAR Technologies (WHTCF) closed a $62 million Series B Preferred financing on December 8, 2025, issuing 41,352,598 Series B Shares at $1.50 per share to institutional investors including Mawer, Edgepoint and PICTON, plus WELL and management participation.
The Series B Shares match Series A rights, convert into subordinate voting shares on a qualifying liquidity event, accrue dividends starting in 2026, and are redeemable after December 31, 2026. Proceeds are intended for acquisitions, AI-related innovation, organic growth and general corporate purposes. WELLSTAR is targeting a public listing in 2026.
WELL Health Technologies (OTCQX: WHTCF) reported strong Q3 2025 momentum in its Canadian Patient Services business with quarterly revenue > $110 million, a 41% YoY increase. WELL disclosed organic-growth detail: WMC overall +16% (same-clinic +10%, absorption +6%) and WDC overall +16% (same-clinic +16%).
The company reported 92% core digitization progress for clinics in-network >9 months and said it created >45,000 new primary care patient openings across Ontario, Alberta, and Manitoba on June 24, 2025, of which 25,000 were filled by Oct 31, 2025, targeting full fill by end of Q1 2026.